Effects of dexmedetomidine on heart arrhythmia prevention in off-pump coronary artery bypass surgery: A randomized clinical trial
Background: Arrhythmia occurring during and after surgery is one of the major complications in open-heart surgery. Dexmedetomidine is an intravenous alpha-2 agonist and very specific short-acting drug to protect the various organs against ischemic injuries and blood reflow. However, the effect of...
Main Authors: | Ghasem Soltani, Saeed Jahanbakhsh, Mohammad Abbasi Tashnizi, Mehdi Fathi, Shahram Amini, Nahid Zirak, Shima Sheybani |
---|---|
Format: | Article |
Language: | English |
Published: |
Electronic Physician
2017-10-01
|
Series: | Electronic Physician |
Subjects: | |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718864/ |
Similar Items
-
Frequency of Acute Kidney Injury in Patients Treated With Normal Saline after Off-Pump Coronary Artery Bypass Grafting
by: Shima Sheybani, et al.
Published: (2017-03-01) -
Dexmedetomidine as anesthetic adjunct for fast tracking and pain control in off-pump coronary artery bypass
by: Mohamed Essam Abdel-Meguid
Published: (2013-01-01) -
The effects of dexmedetomidine on attenuation of stress response to endotracheal intubation in patients undergoing elective off-pump coronary artery bypass grafting
by: Sajith Sulaiman, et al.
Published: (2012-01-01) -
A comparative clinical study of dexmedetomidine versus placebo to attenuate hemodynamic response to endotracheal intubation in patients undergoing off pump coronary arterial bypass grafting
by: Soniya R Sulhyan, et al.
Published: (2014-01-01) -
Comparison of the incidence and severity of delirium and biochemical factors after coronary artery bypass grafting with dexmedetomidine: A randomized double-blind placebo-controlled clinical trial study
by: Gholamreza Massoumi, et al.
Published: (2019-03-01)